Meridian Bioscience (VIVO) Financials

$3.89

$-0.03 (-0.77%)

As on 04-Sep-2026 19:57EDT

Market cap

$124 Mln

Revenue (TTM)

$302 Mln

P/E Ratio

--

P/B Ratio

7.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	0.02	4.06	333.02	10.16	317.90	23.98
Cost of Revenue	-0.03	8.14	144.66	11.37	116.75	19.61
Gross Profit	0.04	-4.09	188.36	-1.21	201.15	4.36
Operating Expenses	8.62	15.83	112.41	25.01	107.63	29.76
Operating Profit (EBIT)	-8.61	-11.77	54.39	-14.85	93.03	-5.78
Other Income	--	--	1.12	--	-0.71	--
Profit before Tax	-44.22	-19.51	54.32	-23.66	90.45	-8.17
Provision for Tax	--	--	11.86	--	19.04	--
Profit after Tax (Net Income)	-46.70	-24.36	42.46	-22.05	71.41	-7.57
Minority Interest	--	--	--	--	--	0.39
Consolidated Profit	--	--	42.46	--	71.41	--

Liabilities ($ Mln)	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	-40.54	3.75	368.06	21.62	328.30	40.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	23.85	38.76	37.09	24.74	74.26	22.66
Current Liabilities	54.13	18.92	57.95	23.30	47.16	13.43
Total Liabilities	37.43	61.42	463.10	69.66	449.72	76.51

Assets ($ Mln)	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	19.77	51.05	252.50	47.99	256.92	52.02
Current Assets	17.66	10.36	210.60	21.67	192.81	24.50
Total Assets	--	--	463.10	--	449.72	--
Total Debt*	--	--	30.96	--	65.92	--
Net Current Assets	-36.47	-8.55	152.65	-1.63	145.65	11.07

Cashflow ($ Mln)	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	1.49	-5.44	82.36	-5.13	66.87	-15.38
Cash Flow from Investing Activities	--	--	-11.12	--	-40.40	--
Cash from Financing Activities	2.72	6.69	-34.30	3.56	-31.07	23.54
Net Cash Inflow / Outflow	--	--	36.94	--	-4.60	--

Financials Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-1.06	-0.55	0.96	-0.50	1.62	-0.17
Cash EPS ($)	-1.03	-0.52	1.34	-0.46	1.97	-0.12
Adjusted Book Value ($)	--	0.09	8.37	0.49	7.46	0.92
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	0.03	-0.12	1.87	-0.12	1.52	-0.35
Free Cash Flow per Share ($)	-0.07	-0.23	1.68	-0.24	1.10	-0.37

Profitability Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	253.87	-12.09	10.71	-10.61	20.05	--
ROE (%)	253.87	-13.10	12.19	-12.61	24.80	--
ROA (%)	-94.49	-9.29	9.30	-8.49	16.70	--
EBIT Margin (%)	--	--	16.67	--	29.04	--
Net Margin (%)	-291,875.00	-600.62	12.71	-217.07	22.51	-31.58
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	-1.00	-0.60	0.05	-0.58	0.25	--
EBIT Growth (%)	--	--	-39.88	--	49.10	--
Net Profit Growth (%)	-91.75	-10.43	-40.54	-191.30	54.61	--
EPS Growth (%)	-0.92	-0.10	-0.41	-1.91	0.51	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	--	32.67	-60.69	11.86	-128.90
Price / Book Value	--	--	3.77	61.92	2.58	24.15
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	18.56	--	8.02	--
Close Price ($)	--	--	31.53	30.42	19.24	22.18
High Price ($)	--	--	34.38	31.93	30.65	30.65
Low Price ($)	--	--	17.20	17.04	15.45	12.98
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	--	--	0.08	--	0.20	--
Short term debt to equity ratio	--	--	0.00	--	0.01	--
Current Ratio	0.33	0.55	3.63	0.93	4.09	1.82
Quick Ratio	0.30	0.44	2.46	0.85	2.46	1.68
Interest Coverage	--	--	46.68	--	49.16	--

Operating Efficiency Ratios	Jun-24	Jun-23	Sep-22	Jun-22	Sep-21	Jun-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	--	40.67	14.18	38.05	16.85	20.68
Asset Turnover	0.00	0.02	0.73	0.04	0.74	--
Receivable days	18,821.79	2,201.59	55.28	1,032.37	52.90	331.13
Inventory Days	-25,438.99	1,568.12	182.62	1,264.55	216.03	588.75
Payable days	-126,471.19	571.47	37.19	279.37	37.03	151.70
Cash Conversion Cycle	119,854.00	3,198.24	200.71	2,017.55	231.91	768.18